Skip to main content
Top
Published in: Inflammation Research 12/2011

01-12-2011 | Original Research Paper

Association of tumor necrosis factor-α (TNF-α) promoter polymorphisms with overweight/obesity in a Korean population

Authors: Gyeong-Im Yu, Eunyoung Ha, Sung-Hee Park, Jae-Hyung Park, Hyun-Sook Jang, Jae-Hoon Bae, In-Sung Chung, Dong-Hoon Shin, Dae-Kyu Song

Published in: Inflammation Research | Issue 12/2011

Login to get access

Abstract

Objective

Obesity is characterized by the activation of an inflammatory process leading to an increase in proinflammatory cytokines and adipokines. This study was designed to investigate the genetic association between tumor necrosis factor-α (TNF-α) polymorphisms and the risk of obesity in the Korean population.

Methods

Three single nucleotide polymorphisms [G-238A (rs361525), C-857T (rs1799724), and C-863A (rs1800630)] in the promoter region of TNF-α gene were analyzed in 123 control [body mass index (BMI) between 18 and 23] and 208 overweight/obese (BMI ≥ 23) subjects.

Results

The mean values of BMI in the control and overweight/obese groups were 21.1 ± 1.4 and 25.4 ± 1.8, respectively. Of the three SNPs, G-238A presented a significant association with overweight/obesity in the codominant model; the frequency of the G/G genotype in the overweight/obese group was 9.3% higher than that in the control group (P = 0.0046). When control and overweight/obesity subjects were combined together and analyzed, the level of high-density lipoprotein (HDL) was significantly higher in the C-857T C/C type SNP (P < 0.05).

Conclusions

The results of this study suggest that the G allele of G-238A in TNF-α gene may be a risk factor for overweight/obesity in the Korean population and that the C allele of C-857T may be an protective factor in relation to the HDL level in the general Korean population.
Literature
1.
go back to reference Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–43.PubMed Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–43.PubMed
2.
go back to reference Wilson PWF, Grundy SM. The metabolic syndrome: practical guide to origins and treatment: Part I. Circulation. 2003;108:1422–5.PubMedCrossRef Wilson PWF, Grundy SM. The metabolic syndrome: practical guide to origins and treatment: Part I. Circulation. 2003;108:1422–5.PubMedCrossRef
3.
go back to reference Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.PubMedCrossRef Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.PubMedCrossRef
4.
go back to reference Maes HHM, Neale MC, Eaves LJ. Genetic and environmental factor in relative body weight and human adiposity. Behav Genet. 1997;27:325–51.PubMedCrossRef Maes HHM, Neale MC, Eaves LJ. Genetic and environmental factor in relative body weight and human adiposity. Behav Genet. 1997;27:325–51.PubMedCrossRef
5.
go back to reference Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature. 2000;404:644–51.PubMed Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature. 2000;404:644–51.PubMed
6.
go back to reference Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, et al. The human obesity genemap: the 2005 update. Obesity. 2006;14:529–644.PubMedCrossRef Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, et al. The human obesity genemap: the 2005 update. Obesity. 2006;14:529–644.PubMedCrossRef
8.
go back to reference Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 1993;268:26055–8.PubMed Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 1993;268:26055–8.PubMed
9.
go back to reference Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.PubMedCrossRef Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.PubMedCrossRef
10.
go back to reference Sethi JK, Hotamisligil GS. The role of TNF-α in adipocyte metabolism. Semin Cell Dev Biol. 1999;10:19–29.PubMedCrossRef Sethi JK, Hotamisligil GS. The role of TNF-α in adipocyte metabolism. Semin Cell Dev Biol. 1999;10:19–29.PubMedCrossRef
11.
go back to reference Hotamisligil G, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271:665–8.PubMedCrossRef Hotamisligil G, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271:665–8.PubMedCrossRef
12.
go back to reference Lang C, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130:43–52.PubMedCrossRef Lang C, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130:43–52.PubMedCrossRef
13.
go back to reference Feingold K, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987;80:184–90.PubMedCrossRef Feingold K, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987;80:184–90.PubMedCrossRef
14.
go back to reference Stephens J, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3–L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem. 1991;266:21839–45.PubMed Stephens J, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3–L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem. 1991;266:21839–45.PubMed
15.
go back to reference Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, et al. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol. 1996;10:1457–66.PubMedCrossRef Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, et al. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol. 1996;10:1457–66.PubMedCrossRef
16.
go back to reference Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 1993;268:26055–8.PubMed Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 1993;268:26055–8.PubMed
17.
go back to reference Stephens JM, Lee JL, Pilch PF. Tumor necrosis factor-α induced insulin resistance in 3T3–L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and glut4 expression without loss of insulin receptor-mediated signal transduction. J Biol Chem. 1997;272:971–6.PubMedCrossRef Stephens JM, Lee JL, Pilch PF. Tumor necrosis factor-α induced insulin resistance in 3T3–L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and glut4 expression without loss of insulin receptor-mediated signal transduction. J Biol Chem. 1997;272:971–6.PubMedCrossRef
18.
go back to reference Skoog T, van’t Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C → A substitution at position –863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999;8:1443–9.PubMedCrossRef Skoog T, van’t Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C → A substitution at position –863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999;8:1443–9.PubMedCrossRef
19.
go back to reference Kroeger K, Carville KS, Abraham LJ. The –308 tumor necrosis factor-alpha promoter polymorphism affects transcription. Mol Immunol. 1997;5:391–9.CrossRef Kroeger K, Carville KS, Abraham LJ. The –308 tumor necrosis factor-alpha promoter polymorphism affects transcription. Mol Immunol. 1997;5:391–9.CrossRef
20.
go back to reference Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, et al. Different transcriptional activity and in vitro TNF-alpha production inpsoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000;114:1180–3.PubMedCrossRef Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, et al. Different transcriptional activity and in vitro TNF-alpha production inpsoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000;114:1180–3.PubMedCrossRef
21.
go back to reference Bayley J, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the –376, –308, –244, and –238 polymorphic sites of the TNF-alpha promoter. Cytokine. 2001;14:316–23.PubMedCrossRef Bayley J, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the –376, –308, –244, and –238 polymorphic sites of the TNF-alpha promoter. Cytokine. 2001;14:316–23.PubMedCrossRef
22.
go back to reference Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51:605–12.PubMedCrossRef Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51:605–12.PubMedCrossRef
23.
go back to reference Koch M, Rett K, Volk A, Maerker E, Haist K, Weisser M, et al. The tumour necrosis factor alpha –238 G → A and –308 G → A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II diabetic patients. Diabetologia. 2000;43:181–4.PubMedCrossRef Koch M, Rett K, Volk A, Maerker E, Haist K, Weisser M, et al. The tumour necrosis factor alpha –238 G → A and –308 G → A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II diabetic patients. Diabetologia. 2000;43:181–4.PubMedCrossRef
24.
go back to reference Fernandez-Real J, Gutierrez C, Ricart W, Casamitjana R, Fernández-Castañer M, Vendrell J, et al. The TNF-alpha gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes. 1997;46:1468–72.PubMedCrossRef Fernandez-Real J, Gutierrez C, Ricart W, Casamitjana R, Fernández-Castañer M, Vendrell J, et al. The TNF-alpha gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes. 1997;46:1468–72.PubMedCrossRef
25.
go back to reference Day C, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia. 1998;41:430–4.PubMedCrossRef Day C, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia. 1998;41:430–4.PubMedCrossRef
26.
go back to reference Wybranska I, Malczewska-Malec M, Niedbal S, Naskalski JW, Dembinska-Kiec A. The TNF-alpha gene NcoI polymorphism at position –308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity. Clin Chem Lab Med. 2003;41:501–10.PubMedCrossRef Wybranska I, Malczewska-Malec M, Niedbal S, Naskalski JW, Dembinska-Kiec A. The TNF-alpha gene NcoI polymorphism at position –308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity. Clin Chem Lab Med. 2003;41:501–10.PubMedCrossRef
27.
go back to reference Nicaud V, Raoux S, Poirier O, Cambien F, O’Reilly DS, Tiret L. The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II. Atherosclerosis. 2002;161:317–25.PubMedCrossRef Nicaud V, Raoux S, Poirier O, Cambien F, O’Reilly DS, Tiret L. The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II. Atherosclerosis. 2002;161:317–25.PubMedCrossRef
28.
go back to reference International Diabetes Institute. The Asia-Pacific perspective: redefining obesity and its treatment. Geneva: World Health Organization; 2000. p. 1–55. International Diabetes Institute. The Asia-Pacific perspective: redefining obesity and its treatment. Geneva: World Health Organization; 2000. p. 1–55.
29.
go back to reference World Health Organization. Obesity: preventing and managing the global epidemic. WHO obesity technical report series No. 894. Geneva: World Health Organization; 2000. World Health Organization. Obesity: preventing and managing the global epidemic. WHO obesity technical report series No. 894. Geneva: World Health Organization; 2000.
30.
31.
32.
go back to reference Hamminga EA, van der Lely AJ, Neumann HA, Thio HB. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses. 2006;67:768–73.PubMedCrossRef Hamminga EA, van der Lely AJ, Neumann HA, Thio HB. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses. 2006;67:768–73.PubMedCrossRef
33.
go back to reference Nicaud V, Raoux S, Poirier O, Cambien F, O’Reilly DS, Tiret L. The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II. Atherosclerosis. 2002;161:317–25.PubMedCrossRef Nicaud V, Raoux S, Poirier O, Cambien F, O’Reilly DS, Tiret L. The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II. Atherosclerosis. 2002;161:317–25.PubMedCrossRef
34.
go back to reference Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegård J, Wiman B, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis. 2006;187:408–14.PubMedCrossRef Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegård J, Wiman B, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis. 2006;187:408–14.PubMedCrossRef
35.
go back to reference Romeo S, Sentinelli F, Capici F, Arca M, Berni A, Vecci E, et al. The G-308A variant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Med Genet. 2001;2:10.PubMedCrossRef Romeo S, Sentinelli F, Capici F, Arca M, Berni A, Vecci E, et al. The G-308A variant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Med Genet. 2001;2:10.PubMedCrossRef
36.
go back to reference Jae-Young Um, Jae-Hwang Park, Hyung-Min Kim. Gene polymorphisms in tumor necrosis factor locus and waist–hip ratio in obese Koreans. Clin Chim Acta. 2003;338(1-2):117–22.CrossRef Jae-Young Um, Jae-Hwang Park, Hyung-Min Kim. Gene polymorphisms in tumor necrosis factor locus and waist–hip ratio in obese Koreans. Clin Chim Acta. 2003;338(1-2):117–22.CrossRef
37.
go back to reference Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011;13(1):11–22.PubMedCrossRef Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011;13(1):11–22.PubMedCrossRef
38.
go back to reference Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000;114(6):1180–3.PubMedCrossRef Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000;114(6):1180–3.PubMedCrossRef
39.
go back to reference Yamashina M, Kaneko Y, Maesawa C, Kajiwara T, Ishii M, Fujiwara F, et al. Association of TNF-alpha gene promoter C-857T polymorphism with higher serum LDL cholesterol levels and carotid plaque formation in Japanese patients with type 2 diabetes. Tohoku J Exp Med. 2007;211(3):251–8.PubMedCrossRef Yamashina M, Kaneko Y, Maesawa C, Kajiwara T, Ishii M, Fujiwara F, et al. Association of TNF-alpha gene promoter C-857T polymorphism with higher serum LDL cholesterol levels and carotid plaque formation in Japanese patients with type 2 diabetes. Tohoku J Exp Med. 2007;211(3):251–8.PubMedCrossRef
Metadata
Title
Association of tumor necrosis factor-α (TNF-α) promoter polymorphisms with overweight/obesity in a Korean population
Authors
Gyeong-Im Yu
Eunyoung Ha
Sung-Hee Park
Jae-Hyung Park
Hyun-Sook Jang
Jae-Hoon Bae
In-Sung Chung
Dong-Hoon Shin
Dae-Kyu Song
Publication date
01-12-2011
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 12/2011
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-011-0372-z

Other articles of this Issue 12/2011

Inflammation Research 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.